News

Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

exercise aerobic training fitness resistance training older woman

Researchers tracked data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

brain stethoscope alzheimer's dementia

Researchers in Boston are set to co-lead a long-term study on the aging brain and factors that make individuals more vulnerable to neural injury and cognitive decline. 

Thumbnail

The U.S. Department of Justice said the settlement will save citizens of the state money and open up the market to competition.

nursing home elderly patient

Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.  

Thumbnail

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Siemens Healthineers invests $30M into new radiopharma facility

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

Eko Health announced former U.S. Surgeon General Jerome Adams, MD, MPH, FASA, a board-certified anesthesiologist and executive director of the Center for Community Health Enhancement and Learning at Purdue University, joined the company as a distinguished medical advisor.

"Eko is transforming how we detect cardiovascular disease—making cutting-edge, AI-powered tools accessible to frontline providers," said former U.S. Surgeon General Jerome Adams, MD.

Australia-based Artrya Limited said its Salix Coronary Plaque module AI-powered cloud platform offers near-real time, point-of-care CCTA assessment and management of coronary artery disease.

Australia-based Artrya Limited says its AI-enabled Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment and management of coronary artery disease. 

Recor Medical's Paradise Ultrasound Renal Denervation System

In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 

interventional ultrasound

Removals are routinely completed in outpatient offices, but occasionally when complications make them more challenging, providers turn to additional tools for assistance. 

Around the web

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

Researchers tracked data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.